Prudential Financial’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,300
Closed -$20.1K 2634
2023
Q1
$20.1K Sell
10,300
-4,600
-31% -$10.9K ﹤0.01% 2567
2022
Q4
$33.5K Buy
14,900
+4,600
+45% +$10.7K ﹤0.01% 2531
2022
Q3
$25K Hold
10,300
﹤0.01% 2620
2022
Q2
$21K Buy
+10,300
New +$23.8K ﹤0.01% 2644
2018
Q4
Sell
-29,800
Closed -$170K 2390
2018
Q3
$170K Buy
29,800
+100
+0.3% +$589 ﹤0.01% 2348
2018
Q2
$182K Buy
29,700
+9,100
+44% +$56.9K ﹤0.01% 2354
2018
Q1
$138K Buy
+20,600
New +$142K ﹤0.01% 2280

Other funds holding CPIX

Prudential Financial's CPIX Position: Q2 2023 in Review

Prudential Financial sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2023, closing a stake of 10,300 shares — an estimated $20.1K sold.

Prudential Financial first reported a position in CPIX in Q1 2018 and held it in 7 quarters. The position peaked at $182K in Q2 2018. 23 funds tracked by Wall St. Rank hold CPIX as of Q2 2023.

  • Prudential Financial reported no remaining Cumberland Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Prudential Financial sold 10,300 Cumberland Pharmaceuticals shares in Q2 2023, an estimated $20.1K.
  • Prudential Financial first reported a position in Cumberland Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Prudential Financial's Cumberland Pharmaceuticals position peaked at $182K in Q2 2018.
  • 23 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.